Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2009
06/04/2009WO2009070720A1 Bioengineered tissue constructs and methods for production and use
06/04/2009WO2009070683A1 Fibroblast derived stem cells
06/04/2009WO2009070592A2 Differentiation of human embryonic stem cells
06/04/2009WO2009069819A1 Living body holding method, living body test method, living body growing method, living body holding sheet, and living body processing device
06/04/2009WO2009069355A1 Method for screening of therapeutic agent for allergic airway inflammation and/or airway hypersensitivity using il-17rb-positive nkt cell
06/04/2009WO2009069022A1 Composition comprising calcium ions and at least one proteolytic enzyme for use in the in vitro and in vivo regeneration of cutaneous and connective tissues
06/04/2009WO2009068649A2 Antigen-binding constructs
06/04/2009WO2009068615A1 Ex vivo method for producing a preparation containing cd4+ t cells specific for ebv structural antigens
06/04/2009WO2009068575A1 Compositions for treating an intestinal inflammatory condition
06/04/2009WO2009067820A1 14-3-3 antagonists for the prevention and treatment of arthritis
06/04/2009WO2009047498A3 Mutant enzymes
06/04/2009WO2009045308A3 Enhanced generation of cytotoxic t-lymphocytes by il-21 mediated foxp3 suppression
06/04/2009WO2009042522A3 Microfluidic lysis
06/04/2009WO2009040674A3 A public and immunogenic cd4+ t cell epitope of the hiv tat protein and its applications
06/04/2009WO2009037439A3 Methods of switching the phenotype of t cells by transgenic lineage factor foxp3
06/04/2009WO2009036451A3 New dendritic cells
06/04/2009WO2009036220A3 Compositions and methods for improving the functional efficacy of stem cell-derived cardiomyocytes
06/04/2009WO2009022339A9 Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair
06/04/2009WO2008022963A3 Isolation and characterization of a novel pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains
06/04/2009WO2008017604A3 Sandalwood aroma receptors
06/04/2009WO2006127768A3 Microscale micropatterned engineered in vitor tissue
06/04/2009US20090144863 Expression Enhancing Intron Sequences
06/04/2009US20090144859 GTP Binding Stress-Related Proteins and Methods of Use in Plants
06/04/2009US20090144856 Methods for producing pathogen-resistant plants with allene oxide synthase and divinyl ether synthase, and the amino acid and nucleotide sequences thereof
06/04/2009US20090144855 Compositions and Methods Comprising Stinging Capsules/Cells For Delivering a Biologically Active Agent Into a Plant Cell
06/04/2009US20090144853 Control of Gene Expression in Plants
06/04/2009US20090144852 Axmi-066 and axmi-076: delta-endotoxin proteins and methods for their use
06/04/2009US20090144851 Plant amino acid biosynthetic enzymes
06/04/2009US20090144848 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
06/04/2009US20090144847 Transgenic seed for crops with enhanced agronomic traits; increased yield
06/04/2009US20090144845 Ptilotus Variety BEPT107
06/04/2009US20090144841 Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (MRP-1) and their use in diagnostic and therapeutic applications
06/04/2009US20090143863 Method for disc regeneration using stem cell derived chondroprogenitors
06/04/2009US20090143766 Hydroxyphenyl cross-linked macromolecular network and applications thereof
06/04/2009US20090143583 Transfection reagents
06/04/2009US20090143568 Recombinant gelatins
06/04/2009US20090143451 Compounds that increase telomerase reverse transcriptase (tert) expression and methods for using the same
06/04/2009US20090143427 4-Oxoquinoline derivatives
06/04/2009US20090143376 Fused Heterocyclic Compounds and Their Use as Sirtuin Modulators
06/04/2009US20090143323 Double-stranded ribonucleic acid havng a sense strand and an antisense strand with specific sequences; mediating RNA interference; decreasing virus titre and sustaining platelet count and lymphocyte count
06/04/2009US20090143320 Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis
06/04/2009US20090143303 Anti-invasive and anti-angiogenic compositions
06/04/2009US20090143298 Broad-Spectrum Delta-Endotoxins and Method and Kit for Detecting Same and for Detecting Polynucleotides Encoding Same
06/04/2009US20090143297 Modulators of antiestrogen pharmacology
06/04/2009US20090143296 Methods and compositions for the repair and/or regeneration of damaged myocardium
06/04/2009US20090143292 Liquid Formulation of G-CSF Conjugate
06/04/2009US20090143278 Process for preparing bioactive protein-enriched whey products
06/04/2009US20090143276 Trimeric IL-1Ra
06/04/2009US20090143248 Biologically active C-terminal arginine-containing peptides
06/04/2009US20090143241 Antibacterial and plasmid elimination agents
06/04/2009US20090142855 Polynucleotides and Polypeptides of the IL-12 Family of Cytokines
06/04/2009US20090142841 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors
06/04/2009US20090142839 Inducing Premature Senescence to Stabilize Stem Cell Feeder Layer Cells
06/04/2009US20090142837 Method and apparatus for substantially isolating plant tissues
06/04/2009US20090142836 Bioengineered tissue constructs and methods for production and use
06/04/2009US20090142835 Stem cell separating material and method of separation
06/04/2009US20090142834 Multipotent stem cells from peripheral tissues and uses thereof
06/04/2009US20090142833 Pine Cone Extracts and Uses Thereof
06/04/2009US20090142832 Indoles, Derivatives, and Analogs Thereof and Uses Therefor
06/04/2009US20090142831 Placental stem cells
06/04/2009US20090142830 Aqueous Solution for Cell Preservation
06/04/2009US20090142829 Recombinant Constructs And Their Use In Reducing Gene Expression
06/04/2009US20090142807 rabbit-derived immortal B-lymphocyte capable of fusion with a rabbit splenocyte to produce a hybrid cell that produces an antibody; hybridoma produced as a result of the fusion
06/04/2009US20090142801 butyrophilin-like nucleic acids; for diagnosis and treatment of inflammatory bowel diseases and for enhancing a mucosal immune response to an antigen
06/04/2009US20090142800 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/04/2009US20090142794 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors
06/04/2009US20090142786 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/04/2009US20090142782 Using actinobacillus specific immunogolbulins to diagnose gum disease
06/04/2009US20090142780 Methods of donor specific crossmatching
06/04/2009US20090142777 Reagents for the detection of protein phosphorylation in leukemia signaling pathways
06/04/2009US20090142776 Antibody for assaying adamts13 activity and method for assaying the activity
06/04/2009US20090142768 Perforin-2 proteins
06/04/2009US20090142754 RNA Detection Assays
06/04/2009US20090142471 Plant isoflavonoid hydroxylases and methods of use thereof
06/04/2009US20090142376 Chlamydia polypeptides and corresponding dna fragments and uses thereof
06/04/2009US20090142364 Method for finding novel peptide immunostimulatory adjuvants, compositions and methods of use
06/04/2009US20090142359 Anti-Her2 antibodies which induce apoptosis in Her2 expressing cells; treating cancer by Her2 overexpression using the antibodies
06/04/2009US20090142358 Human antibodies specific to kdr and uses thereof
06/04/2009US20090142351 Human and rat PGC-3, PPAR-gamma coactivations and splice variants thereof
06/04/2009US20090142349 CD19 Antibodies And Their uses
06/04/2009US20090142348 Novel Gene Disruptions, Compositions and Methods Relating Thereto
06/04/2009US20090142346 Preventive/Remedy for Cancer
06/04/2009US20090142343 Anti-VEGF antibodies
06/04/2009US20090142339 Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
06/04/2009US20090142329 Interleukin-1 Beta Converting Enzyme Like Apoptosis Protease-3 and 4
06/04/2009US20090142320 METHOD TO MINIMIZE IL-17 PRODUCTION DURING nTREG CELL EXPANSION
06/04/2009US20090142319 METHOD TO EXPAND nTREG CELLS USING PI-3K ANTAGONIST
06/04/2009US20090142318 METHOD TO EXPAND nTREG CELLS USING p70 S6 KINASE ANTAGONIST
06/04/2009US20090142316 Use of Dendrimers to Stimulate Cell Growth
06/04/2009US20090142311 Engineered intervertebral disc tissue
06/04/2009US20090142308 Methods for treating autoimmune disease by inducing autoantigen-specific regulatory CD4+ T cells
06/04/2009US20090142307 Shape-Based Approach for Scaffoldless Tissue Engineering
06/04/2009US20090142305 Pegylated fibrinogen-based biomatrix
06/04/2009US20090142302 Insulin-like growth factor binding protein 7 for treatment of cancer
06/04/2009US20090142300 Compositions and methods related to toll-like receptor-3
06/04/2009US20090142296 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue
06/04/2009US20090142280 Protective skin care peptides
06/04/2009US20090142272 Pfks as modifiers of the igfr pathway and methods of use
06/04/2009US20090142271 Dendritic cells
06/04/2009US20090142266 Peptides derived from maurocalcine used as vectors for intracellular addressing of molecules of interest